nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—Cytolytic hepatitis—Ramipril—type 1 diabetes mellitus	0.167	0.167	CcSEcCtD
Etravirine—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.0298	0.0298	CcSEcCtD
Etravirine—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.0231	0.0231	CcSEcCtD
Etravirine—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.0217	0.0217	CcSEcCtD
Etravirine—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.0209	0.0209	CcSEcCtD
Etravirine—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.0208	0.0208	CcSEcCtD
Etravirine—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.0203	0.0203	CcSEcCtD
Etravirine—Amnesia—Ramipril—type 1 diabetes mellitus	0.02	0.02	CcSEcCtD
Etravirine—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.0198	0.0198	CcSEcCtD
Etravirine—Breast disorder—Ramipril—type 1 diabetes mellitus	0.0169	0.0169	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.0169	0.0169	CcSEcCtD
Etravirine—Gastritis—Ramipril—type 1 diabetes mellitus	0.0166	0.0166	CcSEcCtD
Etravirine—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.016	0.016	CcSEcCtD
Etravirine—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.0159	0.0159	CcSEcCtD
Etravirine—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.0159	0.0159	CcSEcCtD
Etravirine—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.0158	0.0158	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.0143	0.0143	CcSEcCtD
Etravirine—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.0142	0.0142	CcSEcCtD
Etravirine—Renal failure—Ramipril—type 1 diabetes mellitus	0.0142	0.0142	CcSEcCtD
Etravirine—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.0142	0.0142	CcSEcCtD
Etravirine—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.0142	0.0142	CcSEcCtD
Etravirine—Stomatitis—Ramipril—type 1 diabetes mellitus	0.0141	0.0141	CcSEcCtD
Etravirine—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.014	0.014	CcSEcCtD
Etravirine—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.0137	0.0137	CcSEcCtD
Etravirine—Hepatitis—Ramipril—type 1 diabetes mellitus	0.013	0.013	CcSEcCtD
Etravirine—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.0127	0.0127	CcSEcCtD
Etravirine—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.0123	0.0123	CcSEcCtD
Etravirine—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.0117	0.0117	CcSEcCtD
Etravirine—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.0117	0.0117	CcSEcCtD
Etravirine—Mental disorder—Ramipril—type 1 diabetes mellitus	0.0114	0.0114	CcSEcCtD
Etravirine—Malnutrition—Ramipril—type 1 diabetes mellitus	0.0113	0.0113	CcSEcCtD
Etravirine—Tension—Ramipril—type 1 diabetes mellitus	0.0111	0.0111	CcSEcCtD
Etravirine—Nervousness—Ramipril—type 1 diabetes mellitus	0.011	0.011	CcSEcCtD
Etravirine—Tremor—Ramipril—type 1 diabetes mellitus	0.0106	0.0106	CcSEcCtD
Etravirine—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.0105	0.0105	CcSEcCtD
Etravirine—Angioedema—Ramipril—type 1 diabetes mellitus	0.0103	0.0103	CcSEcCtD
Etravirine—Malaise—Ramipril—type 1 diabetes mellitus	0.0102	0.0102	CcSEcCtD
Etravirine—Vertigo—Ramipril—type 1 diabetes mellitus	0.0101	0.0101	CcSEcCtD
Etravirine—Syncope—Ramipril—type 1 diabetes mellitus	0.0101	0.0101	CcSEcCtD
Etravirine—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00993	0.00993	CcSEcCtD
Etravirine—Convulsion—Ramipril—type 1 diabetes mellitus	0.00979	0.00979	CcSEcCtD
Etravirine—Anxiety—Ramipril—type 1 diabetes mellitus	0.00958	0.00958	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00955	0.00955	CcSEcCtD
Etravirine—Discomfort—Ramipril—type 1 diabetes mellitus	0.0095	0.0095	CcSEcCtD
Etravirine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.0094	0.0094	CcSEcCtD
Etravirine—Confusional state—Ramipril—type 1 diabetes mellitus	0.00929	0.00929	CcSEcCtD
Etravirine—Shock—Ramipril—type 1 diabetes mellitus	0.00907	0.00907	CcSEcCtD
Etravirine—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00904	0.00904	CcSEcCtD
Etravirine—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00902	0.00902	CcSEcCtD
Etravirine—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00895	0.00895	CcSEcCtD
Etravirine—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00891	0.00891	CcSEcCtD
Etravirine—Anorexia—Ramipril—type 1 diabetes mellitus	0.00879	0.00879	CcSEcCtD
Etravirine—Insomnia—Ramipril—type 1 diabetes mellitus	0.00834	0.00834	CcSEcCtD
Etravirine—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00828	0.00828	CcSEcCtD
Etravirine—Somnolence—Ramipril—type 1 diabetes mellitus	0.00819	0.00819	CcSEcCtD
Etravirine—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00801	0.00801	CcSEcCtD
Etravirine—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00796	0.00796	CcSEcCtD
Etravirine—Fatigue—Ramipril—type 1 diabetes mellitus	0.00795	0.00795	CcSEcCtD
Etravirine—Constipation—Ramipril—type 1 diabetes mellitus	0.00788	0.00788	CcSEcCtD
Etravirine—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.0076	0.0076	CcSEcCtD
Etravirine—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00754	0.00754	CcSEcCtD
Etravirine—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00729	0.00729	CcSEcCtD
Etravirine—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00729	0.00729	CcSEcCtD
Etravirine—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00679	0.00679	CcSEcCtD
Etravirine—Asthenia—Ramipril—type 1 diabetes mellitus	0.00661	0.00661	CcSEcCtD
Etravirine—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00631	0.00631	CcSEcCtD
Etravirine—Dizziness—Ramipril—type 1 diabetes mellitus	0.0061	0.0061	CcSEcCtD
Etravirine—Vomiting—Ramipril—type 1 diabetes mellitus	0.00586	0.00586	CcSEcCtD
Etravirine—Rash—Ramipril—type 1 diabetes mellitus	0.00581	0.00581	CcSEcCtD
Etravirine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00581	0.00581	CcSEcCtD
Etravirine—Headache—Ramipril—type 1 diabetes mellitus	0.00577	0.00577	CcSEcCtD
Etravirine—Nausea—Ramipril—type 1 diabetes mellitus	0.00547	0.00547	CcSEcCtD
